Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barry

Showing results (671-680 of 674) with videos related to

Pageof 68
Sort By:
You have reached the last page of results.This site can display upto 674 results.
Cell Reports|May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerHolly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Nature Metabolism|August 14, 2023
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic targetJohan Vande Voorde, Rory T Steven, Arafath K Najumudeen, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Pageof 68

Showing results (671-680 of 674) with videos related to

Sort By:
Pageof 68
You have reached the last page of results.This site can display upto 674 results.
Cell Reports|May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerHolly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Nature Metabolism|August 14, 2023
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic targetJohan Vande Voorde, Rory T Steven, Arafath K Najumudeen, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Pageof 68